Deal details
Ouster Inc. (NASDAQ: OUST) Chief Technology Officer Mark Frichtl executed the sale of 40,000 shares of common stock on March 25, 2026, generating proceeds of $837,576. The sale prices ranged from $20.53 to $21.30, levels notably higher than the current quoted price of $17.66. The disposition was carried out under a pre-arranged Rule 10b5-1 trading plan dated December 15, 2025, and the filing with the Securities and Exchange Commission indicates that some of the sales were undertaken for tax planning purposes.
Concurrent option exercise
On the same date, Frichtl exercised options to acquire 40,000 shares of Ouster common stock at an exercise price of $2.13 per share, representing a total cost of $85,200. After these transactions, Frichtl's direct holdings in Ouster amount to 636,882 shares.
Share-price context
The stock has shown divergent moves over different timeframes: a 77% gain over the past year contrasted with a 37% decline over the last six months. The recent sale prices for Frichtl's shares were materially above the current trading level cited in filings, reflecting the stock's intra-period volatility.
Market and analyst reaction
Ouster's most recent quarterly performance provided the backdrop for the insider activity. The company posted about $62 million in revenue for the fourth quarter, topping the Visible Alpha consensus of $41.2 million. GAAP gross margin came in at roughly 60%, ahead of the consensus estimate of 36%. Earnings per share were reported at $0.06, compared with a consensus expectation of a $0.14 loss per share.
Following the results, Cantor Fitzgerald reiterated an Overweight rating on Ouster and kept a $33.00 price target. Oppenheimer raised its price target to $40 and maintained an Outperform rating, citing software progress and the favorable influence of the Stereolabs acquisition on the company’s outlook and guidance.
Valuation and risk profile
Analysis from InvestingPro, as noted in filings, places Ouster among names appearing undervalued versus its Fair Value and lists it on a Most Undervalued roster. The company carries a "FAIR" financial health rating in that analysis, with a tip flagging notable stock-price volatility as a material consideration for investors.
What the filings show - and what they do not
The Form 4 filed with the SEC documents the sale, option exercise, the Rule 10b5-1 trading plan date, and the stated tax-planning purpose. The filing and accompanying market data provide clear transactional and performance figures but do not offer further commentary from company management or the insider about the motivations beyond tax planning or future intentions.
This article presents the disclosed insider transaction and recent financial and analyst information related to Ouster as reported in regulatory filings and public analyst commentary.